«Vaksiner virker gjennom flokkimmunitet. En vaksine forbeholdt de rike er derfor en ubrukelig vaksine, og ikke løsningen på pandemien vi lever under». Les innlegget vårt om en COVID-19 vaksine i Dagens Medisin! https://t.co/pf4juVepRB
Hvad driver grundforskningen på universiteterne? Har forskere et ansvar for senere lægemidler udviklet på baggrund af deres ideer? Vi har spurgt Anders Nykjær, Professor i Neuroscience ved Aarhus Universitet om hans syn på sagen https://t.co/hl9JlbzRtd.
#UAEM#takebackourmeds2019
High priced medicines are an issue for countries all around the world and result in millions of unnecessary deaths.
Even if you as an individual are privileged enough to never experience this issue first-hand, your country’s health system will certainly be feeling the strain.
A key argument pharma companies use to defend their high medicine prices is that they need to recover R&D costs.
But did you know that a significant proportion of drugs wouldn’t exist without the support of publicly funded research?
#AccessToMedicinesWeek2019
Today marks the first day of Access to Medicines Week 2019 in Europe! It’s going to be an amazing week full of student activism across the continent advocating for access to medicines worldwide.
#AccessToMedicinesWeek2019#TakeBackOurMeds2019
The UK has isolated itself from almost every other country in the world by refusing to support a global agreement designed to reveal many of the secrets that keep medicine prices high. Their friends in big pharma will be very pleased. Patients, not so much https://t.co/RcYSSzh35f
Tomorrow marks the end of the #TransparencyResolution negotiations at #WHA72
Will UK 🇬🇧 Germany 🇩🇪 Japan 🇯🇵 Switzerland 🇨🇭 and US 🇺🇸 stand for the interests of their people and healthcare systems? Or will they choose to protect big pharma’s lies over people’s health?
Portugal co-sponsors the #TransparencyResolution at #WHA72 - Stating that transparency on R&D costs is about respect for tax payers money and human rights!! #NoMoreSecrets
Big pharma uses undisclosed 🤫 research and development costs to justify sky-high prices for medicines.
Why do these countries 🇺🇸 🇬🇧 🇩🇪 🇯���� 🇨🇭 🇬🇧 want pharma corporations to keep these costs a secret?
#TransparencyResolution #WHA72 #NoMoreSecrets
Delegates at the #WHA72 PLEASE watch this video: https://t.co/ZlPRSi9vaj
It may seem absurd, but this is the reality of how drug pricing works.
The #TransparencyResolution can help governments get fairer prices so more people can get the treatments they need.
Myth 1 in #WHA72#transparency debate: “Pharma can’t calculate R&D costs per drug – too hard!” US Senate to Gilead in 2014: how much did R&D for Hep C drug sofosbuvir cost? @GileadSciences : $943 million. (p.s. their Hep C revenue >$58 billion)
Myth 2 in #WHA72 debate: “#Transparency will raise drug prices in low-income countries (LICs). Rich countries won't accept them!” HIV and vaccine prices most transparent in world, tks to @WHO@GlobalFund + others. Price differentials betw US and LICs: sustained for years at >200x